Watch Kindred Healthcare's
What analysts say:
- Buy, sell, or hold?: Analysts are bullish on this stock with five analysts rating it as a buy and only one rating it as a sell. Analysts like Kindred Healthcare better than competitor Sun Healthcare Group overall. Analysts still rate the stock a moderate buy, but they are a bit more wary about it compared to three months ago.
- Revenue forecasts: On average, analysts predict $1.57 billion in revenue this quarter. That would represent a rise of 37.7% from the year-ago quarter.
- Wall Street earnings expectations: The average analyst estimate is earnings of $0.36 per share. Estimates range from $0.34 to $0.41.
What our community says:
CAPS All-Stars are in strong support of the stock, with 96.3% assigning it an "outperform" rating. The community at large concurs with the All-Stars, with 93.8% awarding it a rating of "outperform." Even with a robust four out of five stars, Kindred Healthcare's CAPS rating falls a little short of the community's upbeat outlook.
Revenue has now gone up for three straight quarters.
One final thing: If you want to keep tabs on Kindred Healthcare movements, and for more analysis on the company, make sure you add it to your Watchlist.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.Earnings estimates provided by Zacks.